Global leadership in design and manufacturing targets better dialysis patient outcomes for U.S. market
Bridgewater, New Jersey – November 11, 2014: Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, announced at Kidney Week 2014, the launch of the next generation ELISIO™ POLYNEPHRON™ Single Use, High-Flux, Hollow-Fiber Dialyzer. This is a superior version of the ELISIO dialyzer that was launched early this year. Both the housing and the membrane are made with material not containing BPA or DEHP. ELISIO™ features a state-of-the-art POLYNEPHRON™ membrane similar in function to that of a human kidney, delivering outstanding solute-removal performance, resulting in superior clearances for better patient outcomes.
“We have taken a dialyzer that delivers excellent clearance and reduced thrombogenicity, and improved it by eliminating any BPA or DEHP,” said Joe Dawson, Senior Vice President, Nipro North America. “Both chemicals are known endocrine disruptors. There are many published studies showing that endocrine disruptors cause adverse effects in animals. As a company that is focused on making products that improve the lives of patients, we are excited that we now have a dialyzer that can do that.”
The ELISIO™ dialyzer’s advanced pore-spinning technology creates more homogenous pore sizes to optimize sieving properties and improve middle molecule clearance. In addition, the unique ripple structure in ELISIO’s fiber creates less dialysate channeling – promoting better diffusive transport while enhancing small molecule clearances, and reducing the risk of fiber leakage.
The new polypropylene housing is also around 25% lighter than current dialyzers in the market, thus making disposal and transportation more cost effective. It also generates 25% less resin waste, and 100˚C lower temperature needed to mold polypropylene parts. Polypropylene also generates 10% less CO2 emission for resin production, and 50% less CO2 emission when incinerated.
“The eco-friendliness of the ELISIO dialyzer is a definite plus,” Dawson said. “In addition, we do not have to compromise on clinical performance, while making a greener dialyzer.”
The ELISIO™ POLYNEPHRON™ Single Use, High-Flux, Hollow-Fiber Dialyzer is available in sizes from 0.9m2 to 2.5m2. ELISIO has received 510 [K] clearance from the U.S. Food and Drug Administration. For complete performance parameters and product specifications, or for more information, visit niproadmin.wpengine.com or call 1-908-393-7030.
About Nipro Medical: Nipro Corporation is a world-leading manufacturer of Renal and Medical-Surgical products. The Company is committed to educating customers and delivering innovative, high quality and value-added solutions to improve patient care. Nipro Medical Corporation is a wholly owned subsidiary of Nipro Corporation, headquartered in Osaka, Japan.
For More Information, Contact:
Marketing Director, North America
Nipro Medical Corporation
- 02 Nov 2017Nipro Medical Corporation Launches the Cellentia®-H Cellulose Triacetate (CTA), Single-Use Dialyzer at the 2017 ASN Kidney Week Conference
- 22 Apr 2016NIPRO MEDICAL CORPORATION LAUNCHES THE SAFETOUCH™ SAFETY NEEDLE
- 18 Feb 2016NIPRO MEDICAL CORPORATION LAUNCHES THE AQUALINER II SECOND GENERATION 0.035” HYDROPHILIC, SUPER-ELASTIC NITINOL GUIDEWIRE IN THE UNITED STATES
- 09 Jul 2015NIPRO MEDICAL CORPORATION INTRODUCES NIPRO VSMART™ SYRINGES AT THE 2015 AMERICAN VETERINARY MEDICAL ASSOCIATION CONVENTION